Best treatments for crohn disease
35 products may treat crohn disease, spanning FDA drug classes such as tumor necrosis factor blocker, interleukin-12 antagonist, interleukin-23 antagonist. The current highest-rated option is amjevita. Ranked below by our independent recall-safety rating (rated where FDA data exists) — not medical advice; always consult a professional.
Quick answer: Of the 35 drugs we list for crohn disease, 5 are available as lower-cost generics, spanning classes such as tumor necrosis factor blocker, interleukin-12 antagonist, interleukin-23 antagonist. They’re ranked by each drug’s FDA recall-safety record — not clinical effectiveness for crohn disease — so confirm the right choice with your prescriber.
Understanding crohn disease
Crohn's disease is a chronic (long-lasting) disease that causes inflammation in the digestive tract. According to MedlinePlus (NLM), it can affect any part of the digestive tract, which runs from the mouth to the anus, but it usually affects the small intestine and the beginning of the large intestine. The most common symptoms, per NIDDK, are diarrhea, cramping and pain in the abdomen, and weight loss; other possible symptoms include anemia, fatigue, fever, joint pain, nausea, appetite loss, vomiting, eye redness or pain, and skin changes such as red, tender bumps. Doctors aren't certain of the exact cause but think an abnormal immune reaction, genes, the environment, and the microbiome play a role; NIDDK notes research has shown smoking may double your chance of developing Crohn's disease. To diagnose it, doctors review your medical and family history, perform a physical exam, and order tests such as blood tests, stool tests, endoscopy (like colonoscopy or upper GI endoscopy), and imaging such as CT scans or MRI; NIDDK says endoscopy tests are the most accurate way to diagnose Crohn's disease. Doctors treat it with medicines and surgery to lower inflammation in the intestines, prevent flares of symptoms, and keep you in remission. There is no cure for Crohn's disease, but treatments can decrease inflammation, relieve symptoms, and prevent complications. This is general information, not medical advice.
First-line treatment
The Updated 2025 ACG Clinical Guideline for the Management of Crohn's Disease (American College of Gastroenterology) suggests against requiring patients to fail conventional therapies such as thiopurines or methotrexate before starting advanced therapies in moderate-to-severe disease, and notes the panel will more readily consider initiating advanced therapies in treatment-naive patients, particularly those with high-risk features. The guideline reflects agents including anti-TNF therapies, vedolizumab, ustekinumab, IL-23 antagonists, and JAK inhibitors for induction and maintenance. It gives a strong recommendation to limit systemic corticosteroids, as induction-only agents, to fewer than 3 months, with a structured taper and rapid transition to steroid-sparing regimens. NIDDK similarly lists corticosteroids for short-term use only, immunosuppressants, biologics, and a small-molecule medicine, plus surgery when medicine is not enough. Treatment is individualized by a clinician based on symptoms, where inflammation is located, and other factors.
Top-rated picks for crohn disease: 1. Amjevita · 2. Cyltezo · 3. Humira
| # | Drug | Rating | Type | Form | Class | Generic? | Pharmacy pays | |
|---|---|---|---|---|---|---|---|---|
| 1 | 72/100 | Prescription | Injectable | — | No data | — | View → | |
| 2 | 72/100 | Prescription | Kit | — | No data | — | View → | |
| 3 | 72/100 | Prescription | Kit | Tumor Necrosis Factor Blocker | No data | — | View → | |
| 4 | 72/100 | Prescription | Injectable | — | No data | — | View → | |
| 5 | 70/100 | Prescription | Injectable | Tumor Necrosis Factor Blocker | No data | — | View → | |
| 6 | 70/100 | Prescription | Injectable | Interleukin-12 Antagonist | No data | — | View → | |
| 7 | 70/100 | Prescription | Solution | Folate Analog Metabolic Inhibitor | Generic | $5 | View → | |
| 8 | 68/100 | Prescription | Injectable | — | No data | — | View → | |
| 9 | 68/100 | Prescription | Kit | — | No data | — | View → | |
| 10 | 68/100 | Prescription | Injectable | — | No data | — | View → |
Narrow by drug class
Explore the class hubs: folate analog metabolic inhibitor · tumor necrosis factor blocker · interleukin-12 antagonist
Full ranking · 35 treatments
amjevita
Boxed warningPrescriptionFDA-sourced
Amjevita (Adalimumab-Atto) is a medication used to treat Juvenile Arthritis, Rheumatoid Arthritis, Ulcerative Colitis, Crohn Disease.
Price varies
cyltezo
Boxed warningPrescriptionFDA-sourced
Cyltezo (Adalimumab-Adbm) is a medication used to treat Juvenile Arthritis, Rheumatoid Arthritis, Ulcerative Colitis, Crohn Disease.
Price varies
humira
Boxed warningPrescriptionFDA-sourced
Humira (Adalimumab) is a tumor necrosis factor blocker used to treat Juvenile Arthritis, Rheumatoid Arthritis, Ulcerative Colitis, Crohn Disease.
Price varies
wezlana
PrescriptionFDA-sourced
Wezlana (Ustekinumab-Auub) is a medication used to treat Ulcerative Colitis, Crohn Disease, Psoriasis, Psoriatic Arthritis.
Price varies
cimzia
Boxed warningPrescriptionFDA-sourced
Cimzia (Certolizumab Pegol) is a tumor necrosis factor blocker used to treat Rheumatoid Arthritis, Crohn Disease, Ankylosing Spondylitis, Psoriatic Arthritis.
Price varies
imuldosa
PrescriptionFDA-sourced
Imuldosa (Ustekinumab-Srlf) is an interleukin-12 antagonist used to treat Ulcerative Colitis, Crohn Disease, Psoriasis, Psoriatic Arthritis.
Price varies
- Xatmep
- Hyrimoz
- Idacio
- Otulfi
- Tyruko
- Hulio
- Ixifi
- Methotrexate Lpf
- Methotrexate Preservative Free
- Anthim
- Entyvio
- Hadlima
- Inflectra
- Jylamvo
- Pyzchiva
- Rasuvo
- Remicade
- Renflexis
- Selarsdi
- Simlandi
- Starjemza
- Stelara
- Steqeyma
- Thalomid
- Tysabri
- Yesintek
- Yuflyma
- Yusimry
- Zymfentra
Frequently asked
- What treats crohn disease?
- Our catalog lists 35 products that may treat crohn disease, based on NIH RxClass (MED-RT “may treat”) drug-classification data — not the verbatim FDA label. They're rated where FDA recall-safety data exists; the current top-rated option is amjevita.
- What is the best-rated treatment for crohn disease?
- By our independent recall-safety rating — not an efficacy measure — amjevita ranks highest among the products we list for crohn disease. Always consult a professional.
- How are these treatments ranked?
- By our independent score, currently based on FDA regulatory recall-safety data (the methodology blends additional sources as they come online). See the How we rate page.
- What types of drugs treat crohn disease?
- Treatments for crohn disease span FDA drug classes including tumor necrosis factor blocker, interleukin-12 antagonist, interleukin-23 antagonist, folate analog metabolic inhibitor, anthrax protective antigen-directed antibody. Compare every option side by side, ranked by independent rating, above.
Treatment associations are derived from NIH RxClass (MED-RT “may treat”) drug-classification data — not the verbatim FDA label. This is general reference, not medical advice — always consult a licensed professional.
Sources
The clinical overview above is written from these authoritative public-health and medical-society sources, independently reviewed against each.
- Crohn's Disease — MedlinePlus (NLM) ↗
- Symptoms & Causes of Crohn's Disease — NIDDK (NIH) ↗
- Diagnosis of Crohn's Disease — NIDDK (NIH) ↗
- Treatment for Crohn's Disease — NIDDK (NIH) ↗
- Crohn's Disease — NIDDK (NIH) ↗
- Updated 2025 ACG Clinical Guideline for the Management of Crohn's Disease — American College of Gastroenterology ↗